AxoSim Posters Featured at SOT 2024 Annual Meeting
News and Blog
The Society of Toxicology (SOT) brought together more than 5,000 people for its 63rd Annual Meeting and ToxExpo March 10 – 24 in Salt Lake City, Utah. Five members of the AxoSim team attended the […]
Read More
Rare Disease Day 2024 – Lori’s Story
News and Blog
More than 300 million people globally live with a rare disease, and just 100,000 live with Guillain–Barré Syndrome (GBS). Rare Disease Day is observed annually on the last day of February to increase awareness of […]
Read More
AxoSim Appoints Two Biotech Industry Veterans as Co-Chairs of Its Board of Directors
News and Blog
AxoSim Appoints Two Biotech Industry Veterans as Co-Chairs of Its Board of Directors —Serial Entrepreneurs Dale Pfost and David Weiner Bring Broad Expertise as AxoSim Expands Its Leadership in Human Organoid Technologies Designed to Make […]
Read More
Fierce Biotech: Organoids touted as future of brain disorder R&D as AxoSim scoops up tech from Vyant subsidiary
News and Blog
RESEARCH As Vyant Bio continues its wind-down, the neuroscience research assets of its subsidiary StemoniX have officially been picked up by AxoSim, a New Orleans-based drug discovery biotech. In an Oct. 24 press release, AxoSim said […]
Read More
Latest Acquisition Lands AxoSim in the News
News and Blog
On Tuesday, October 24, 2023, AxoSim announced the completion of its acquisition of the microBrain™-associated assets of Vyant Bio’s StemoniX subsidiary—news of the acquisition generated excitement among the scientific, pharmaceutical, and business communities. From The […]
Read More
Press Release: AXOSIM EXTENDS LEADERSHIP IN HUMAN ORGANOIDS FOR NEUROLOGICAL DRUG DISCOVERY WITH ACQUISITION OF STEMONIX MICROBRAIN™ TECHNOLOGY
News and Blog
New Orleans, La. ─ October 24, 2023 ─ AxoSim, Inc., a leader in the development and application of live biomimetic human drug discovery platforms for neurological diseases, today announced completion of its acquisition of the microBrain™-associated assets of […]
Read More
AxoSim and its Co-Founder, Michael Moore, PhD, Quoted in the Wire
News and Blog
WIRED recently quoted our Co-Founder Michael J. Moore and mentioned AxoSim and our 3D peripheral nerve model. The article highlights 3d printing of living brain cells from a team of scientists at Monash University. Excerpt […]
Read More
Q&A with Research Assistant Intern Andrew Terrebonne
News and Blog
Tell us the school you attend, grade level and major. I am currently a senior at Tulane University majoring in cell and molecular biology. Why did you want to intern with us at AxoSim? While […]
Read More
Press Release: AxoSim Enters Into a Definitive Agreement to Acquire Vyant Bio’s StemoniX Assets
News and Blog
AxoSim Enters Into a Definitive Agreement to Acquire Vyant Bio’s StemoniX Assets —Combines Three Leading Human Biomimetic Organoid Platform Technologies for Neurological Drug Discovery— —AxoSim Gains microBrainTM Intellectual Property from StemoniX, Along With Expert Scientific […]
Read More
Meet AxoSim | Summer 2023 Conference Schedule
News and Blog
On the Road with AxoSim’s Conference Team | Q&A with Senior Business Development Manager Chelsea Richardson What upcoming conferences is AxoSim a part of this summer? A portion of our team will be headed to […]
Read More